Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers

NCT00796744 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Foot Ulcer, Diabetic
Diabetic Foot

Interventions

DRUG: NorLeu3-A(1-7) in a gel formulation

Sponsor

US Biotest, Inc.

Collaborators

[object Object]
[object Object]